# Glucagon-Like Peptide-1 Receptor Agonists and Pay-Per-Click Direct-to-Consumer Advertising

**Authors:** Daniel Eisenkraft Klein, Marco Zenone, Aaron S. Kesselheim

PMC · DOI: 10.1001/jamanetworkopen.2025.38718 · JAMA Network Open · 2025-10-31

## TL;DR

This study examines how direct-to-consumer advertising is used for a type of diabetes medication called GLP-1RA.

## Contribution

The study provides an analysis of advertising strategies for GLP-1 receptor agonists in a consumer-focused context.

## Key findings

- The study identifies patterns in pay-per-click advertising for GLP-1RA medications.
- It highlights the role of digital marketing in promoting prescription drugs directly to consumers.

## Abstract

This cross-sectional study evaluates the use of direct-to-consumer advertising for a glucagon-like peptide-1 receptor agonist (GLP-1RA).

## Full-text entities

- **Genes:** GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12579337/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12579337/full.md

---
Source: https://tomesphere.com/paper/PMC12579337